Remdesivir (Veklury) for COVID-19

Date: November 30, 2020
Issue #: 
1612Summary: 
The FDA has approved the antiviral drug remdesivir
(Veklury– Gilead) for IV treatment of COVID-19 in
hospitalized patients who are ≥12 years old and weigh
≥40 kg. Hospitalized children who are<12 years old
or weigh<40 kg can receive remdesivir through an
Emergency Use Authorization (EUA). Remdesivir is
the first drug to be approved in the US for treatment
of COVID-19.

Source: The Medical Letter - November 10, 2020 Category: Drugs & Pharmacology Authors: admin Source Type: research